ONCO

NASDAQ 已收盘

Onconetix

2.89 USD
▼-0.27-8.54%
盘后 2.95 +2.08%
2026-11-20
市值
$1.14M
市盈率
—
EPS
-201.63
股息率
—
52 周区间
2.76 – 1,610.00
成交量
43.82K
Beta
2.62
目标价
—
52W 低 2.7652W 高 1,610.00
价格走势

公司简介

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Bl...